Work

427P Pyrotinib plus trastuzumab versus pertuzumab plus trastuzumab in patients with HER2-positive metastatic breast cancer: A multicenter, retrospective study

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.603

Authors: B. Wang, S. You, Y. Xie, F. Xu, D. Sang, T. Luo, P. Yuan

Institutions: Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center, Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Peking University Cancer Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387825833

FWCI: 0.105

Cites:

Cited by: 1

Related to: 10